about
Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trialsEffect of statins on venous thromboembolic events: a meta-analysis of published and unpublished evidence from randomised controlled trialsLack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapyOrganising a World Congress of Epidemiology (WCE): reflections and lessons from the XIX WCE, Scotland.Alcohol-related and hepatocellular cancer deaths by country of birth in England and Wales: analysis of mortality and census data.Tobacco use in 3 billion individuals from 16 countries: an analysis of nationally representative cross-sectional household surveys.Ethnic variations in five lower gastrointestinal diseases: Scottish health and ethnicity linkage study.Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.Iron deficiency anaemia: further education regarding the British Society of Gastroenterology guidelines is requiredAnticipating and managing bleeding complications in patients with coronary stents who are receiving dual antiplatelet treatment.Epidemiology and natural history of patients with NAFLD.Mortality for alcohol-related harm by country of birth in Scotland, 2000-2004: potential lessons for prevention.[Non-alcoholic fatty liver].Combination therapy with clopidogrel and proton-pump inhibitors.Response to letter from S.V. Jargin.Reflections on therapeutic trials in primary biliary cirrhosis: a quality of life oriented counter-view.Familial predisposition to alcoholic liver disease: a case-control study.Methylene blue dye injection: an adjuvant technique in the management of buried bumper syndrome?Iron treatment and inflammatory bowel disease: what happens in real practice?Epidemiology Congresses XIX, XX and beyond: back to the future of population health.Preventing premature mortality in chronic diseases for South Asians in the UK and beyond.Transatlantic reflections: reaching out to tackle global health inequalities.Health is global--what does that mean for the United Kingdom?Coxibs and traditional NSAIDs for pain relief – Authors' replyThe physiological paradox: reframing the polypill as a vaccine for cardiovascular diseaseHow to tackle rising rates of liver disease in the UKMeasuring progress on NCDs: one goal and five targetsNon-alcoholic fatty liver diseaseRisks associated with drug-eluting stentsAutonomic dysfunction in primary biliary cirrhosis correlates with fatigue severityFixed-Dose Unfractionated Heparin vs Low-Molecular-Weight Heparin for Venous ThromboembolismEnoxaparin in Elective Percutaneous Coronary InterventionFondaparinux in Patients With ST-Segment Elevation Myocardial InfarctionUpper gastrointestinal alarms in older peopleUreterosigmoid anastomosis: risk of colorectal cancer and implications for colonoscopistsCeliac disease and small intestinal tubulovillous adenoma: a role for push enteroscopy?
P50
Q21034169-DEA58970-D77B-4E67-92D9-2FB20F122D84Q24619410-115157DD-B47E-4203-9EDE-CC07591325D6Q28483807-36572BCD-9759-4E24-BC7D-14295139CD56Q28732707-FD83427E-F2E6-4498-A3BE-09A28E47A288Q30485376-CC9006DA-9A1F-4378-9750-C095CA2534D2Q33419586-01CA7EFA-600C-408A-98DA-F5CB9281B573Q34294642-234F7336-0E63-4728-AB9C-3EE94F6DA66CQ34397176-04093D23-8E9E-4A9C-8520-415A4CB7F360Q34427089-EA6F229E-BD2F-4264-B1DB-90DA29AFB2E6Q35615790-A16E0BBA-5636-459E-8195-BE2E8D930C17Q35954092-16540A84-43D5-4863-8A52-F38438F5145BQ37903551-2CC1BA11-F53F-4B5F-BF86-9D1149F704BFQ38080108-07911278-8075-482A-B409-1F6A85086BDCQ42675563-C68842E8-4C10-4E16-B6F9-8A0B53D282AAQ43176146-04338311-F000-4DD8-AF2A-6134E0DCB0B5Q43181689-5B8F3CE3-C8E7-473E-8194-BFE2C7BBEDE6Q45928504-74ED0737-C665-41AC-9C1B-897EF52933FEQ46959075-E9F26F3B-EB56-4C73-83C3-67810A0488CDQ47802878-31E1079F-77A8-4E49-A744-D966377C10AFQ50489162-D156EB8C-2D07-459D-9901-18185F8E0C6CQ50726907-44FEE4DE-8537-419B-9ECF-C18469E32BE2Q51630355-57F8C3CB-A42D-441D-AD28-608378035D09Q55175944-79B01389-0B06-4EF7-9E7E-3CC14EF98F6EQ55512861-18BE58A2-CCF6-4C3C-8038-9FEE2A1EB440Q57252894-A5008111-8C41-47E7-A82C-6E56BD92775CQ57710790-58D4426E-EA30-41FF-8E2A-1BFC137B88BEQ57710801-FC22E503-E93A-45E5-94D1-46B411F57DC0Q57710819-0121B8C5-7D3B-4B67-BDEF-E3C5795878B0Q57710824-C7CB2A74-43B9-4241-842E-DA2A12356B07Q57710857-DB1A0B6F-6DE2-4515-BFC8-D95B380141B4Q57710868-9CDE395C-90D4-46F7-A598-D237D733C9A1Q57710875-237468AB-D832-410D-951E-41C05A10E1D6Q57710879-CFEC1404-6630-46FF-8E01-A1D39571E906Q57710888-A9F07551-DE95-4392-8C46-7A3751173B14Q57710893-2BE339E8-5576-4E88-9BC3-F3703AA9D17CQ57710917-0995D7CC-CC15-4A75-B6FF-77E2CBEE214AQ57710923-68A7855B-581C-4437-83D5-E10FCFA3088DQ57710927-690077F8-A853-417F-A511-DEC2D83678D4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
N Bhala
@ast
N Bhala
@en
N Bhala
@es
N Bhala
@nl
N Bhala
@sl
type
label
N Bhala
@ast
N Bhala
@en
N Bhala
@es
N Bhala
@nl
N Bhala
@sl
altLabel
Bhala N
@en
Neeraj Bhala
@en
prefLabel
N Bhala
@ast
N Bhala
@en
N Bhala
@es
N Bhala
@nl
N Bhala
@sl
P106
P31
P496
0000-0003-2502-1177